Keret Yosef 4
4 · Wize Pharma, Inc. · Filed May 1, 2018
Insider Transaction Report
Form 4
Keret Yosef
Director
Transactions
- Award
Stock Option (right to buy)
2018-04-04+25,000→ 0 totalExercise: $3.59Exp: 2025-04-04→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The Stock Option is exercisable in twelve equal installments over the three year period from the date of grant.
- [F2]The Stock Option was granted as compensation for services as a director of the Issuer.